TEGFUMARA Trademark

Trademark Overview

On Friday, November 24, 2023, a trademark application was filed for TEGFUMARA with the United States Patent and Trademark Office. The USPTO has given the TEGFUMARA trademark a serial number of 79388397. The federal status of this trademark filing is REGISTERED as of Tuesday, January 21, 2025. This trademark is owned by Alfred E. Tiefenbacher GmbH & Co. KG. The TEGFUMARA trademark is filed in the Pharmaceutical Products category with the following description:

Drugs for treating neurological disorders
tegfumara

General Information

Serial Number79388397
Word MarkTEGFUMARA
Filing DateFriday, November 24, 2023
Status700 - REGISTERED
Status DateTuesday, January 21, 2025
Registration Number7656588
Registration DateTuesday, January 21, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements

Goods and ServicesDrugs for treating neurological disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 2, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlfred E. Tiefenbacher GmbH & Co. KG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameAlfred E. Tiefenbacher GmbH & Co. KG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameAlfred E. Tiefenbacher GmbH & Co. KG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Thursday, February 1, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, July 4, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, February 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 6, 2024APPLICATION FILING RECEIPT MAILED
Tuesday, June 25, 2024ASSIGNED TO EXAMINER
Wednesday, July 3, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 30, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, July 30, 2024REFUSAL PROCESSED BY MPU
Thursday, September 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, August 17, 2024REFUSAL PROCESSED BY IB
Monday, October 14, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, December 3, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 21, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, April 21, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 17, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 17, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, August 6, 2025FINAL DISPOSITION PROCESSED
Saturday, August 23, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, June 17, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 17, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 1, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, July 1, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, July 18, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, August 6, 2025FINAL DISPOSITION NOTICE SENT TO IB

Related Keywords

tegfumara disorders neurological treating drugs